Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
June 23, 2025
Oncology Weekly News – June 23rd 2025
June 20, 2025
ADA 2025 Preview: Diabetes Care Highlights to Watch
June 20, 2025
Public Health Weekly News – June 20th 2025
June 20, 2025
Vaccines Weekly Update – June 20th 2025
June 20, 2025
Respiratory Weekly News – June 20th 2025
June 19, 2025
Cardiovascular Weekly News – June 19th 2025
June 19, 2025
Rare Diseases Weekly News – June 19th 2025
June 19, 2025
Cell and Gene Therapy Weekly News – June 19th 2025
June 18, 2025
Immunology Weekly News – June 18th 2025
June 18, 2025
Neuroscience Weekly News – June 18th 2025
June 17, 2025
Artificial Intelligence and Digital Health Weekly News – June 17th 2025
June 17, 2025